The House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Health Chair Brett Guthrie (R-KY) recently announced a hearing titled “Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices.” During the hearing, they emphasized that America is a leader in developing cutting-edge biomedical innovation and that countries around the globe look to the FDA for guidance on safe and effective treatments and medical devices.
The Subcommittee on Health hearing will be held on Wednesday, May 22, 2024 at 10:30 AM ET at 2322 Rayburn House Office Building. The hearing will focus on discussing the FDA’s regulation of drugs, biologics, and devices. Witnesses at the hearing will include Dr. Patrizia Cavazzoni, Director of the Center for Drug Evaluation and Research (CDER) at the FDA, Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER) at the FDA, and Dr. Jeffrey Shuren, Director of the Center for Devices and Radiological Health (CDRH) at the FDA.
The hearing will be open to the public and press, with live streaming available online at https://energycommerce.house.gov/. For questions about this hearing please contact Emma Schultheis with Committee staff via email [Emma.Schultheis@mail.house.gov]. To receive press-related queries please reach out to Christopher Krepich via email [Christopher.Krepich@mail